论文部分内容阅读
目的探究肝硬化难治性腹水临床治疗方法和临床疗效。方法肝硬化难治性腹水患者66例,随机分为对照组和观察组,各33例,对照组采用常规治疗方法 ,观察组在对照组基础上采用腹水超滤浓缩回输治疗,治疗后观察比较两组患者临床疗效和各项临床指标变化情况。结果治疗后观察组患者治疗总有效率高于对照组,差异有统计学意义(P<0.05);观察组患者各项临床指标改善情况优于对照组,差异有统计学意义(P<0.05)。结论采用腹水超滤浓缩回输治疗肝硬化难治性腹水,能够有效缓解患者临床症状,改善各项临床指标,治疗总有效率高,临床疗效显著。
Objective To investigate the clinical treatment and clinical efficacy of refractory ascites due to cirrhosis. Methods Sixty-six patients with cirrhosis refractory ascites were randomly divided into control group and observation group, with 33 cases in each group. The control group was treated by routine treatment. The observation group was treated with ultrafiltration and ascites reinfusion in the control group. After treatment, The clinical curative effect and changes of clinical indexes of the two groups were compared. Results After treatment, the total effective rate of observation group was higher than that of control group (P <0.05). The improvement of clinical indexes in observation group was better than that of control group (P <0.05) . Conclusion Ascites ultrafiltration concentrated transfusion for the treatment of cirrhosis refractory ascites, can effectively alleviate the clinical symptoms and improve the clinical indicators, the total effective rate of treatment, clinical significant effect.